TrialClinical drug investigation2013

Dabigatran does not prolong the QT interval with supratherapeutic exposure: a thorough QT study in healthy subjects.

Arne Ring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.